Virtu Financial LLC Pax Medica, Inc. Transaction History

Virtu Financial LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$1.42 - $3.62 $3,839 - $9,788	2,704 Added 26.71%	12,827 $24,000
Q4 2022 Feb 15, 2023	SELL	$1.4 - $53.55 $5,579 - $213,396	-3,985 Reduced 28.25%	10,123 $21,000
Q3 2022 Nov 07, 2022	BUY	$2.25 - $43.69 $31,743 - $616,378	14,108 New	14,108 $34,000

Ticker PXMD
Exchange
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,779,500
Market Cap $1.41M
Description
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, my...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.